Jazz Pharmaceuticals PLC - Asset Resilience Ratio

Latest as of March 2026: 8.68%

Jazz Pharmaceuticals PLC (JAZZ) has an Asset Resilience Ratio of 8.68% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$1.03 Billion

Cash + Short-term Investments

Total Assets

$11.86 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2025)

This chart shows how Jazz Pharmaceuticals PLC's Asset Resilience Ratio has changed over time. Check how strategically is Jazz Pharmaceuticals PLC's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Jazz Pharmaceuticals PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Jazz Pharmaceuticals PLC (JAZZ) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$1.03 Billion	8.68%
Total Liquid Assets	$1.03 Billion	8.68%

Asset Resilience Insights

Limited Liquidity: Jazz Pharmaceuticals PLC maintains only 8.68% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jazz Pharmaceuticals PLC Industry Peers by Asset Resilience Ratio

Compare Jazz Pharmaceuticals PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Akero Therapeutics Inc NASDAQ:AKRO	Biotechnology	55.87%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Zealand Pharma A/S CO:ZEAL	Biotechnology	63.98%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Immunitybio Inc NASDAQ:IBRX	Biotechnology	38.07%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Jazz Pharmaceuticals PLC (2005–2025)

The table below shows the annual Asset Resilience Ratio data for Jazz Pharmaceuticals PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	9.01%	$1.05 Billion	$11.66 Billion	+4.18pp
2024-12-31	4.83%	$580.00 Million	$12.01 Billion	+3.78pp
2023-12-31	1.05%	$120.00 Million	$11.39 Billion	+0.78pp
2022-12-31	0.28%	$30.00 Million	$10.84 Billion	--
2021-12-31	0.00%	$0.00	$12.30 Billion	--
2020-12-31	16.45%	$1.07 Billion	$6.54 Billion	+8.50pp
2019-12-31	7.94%	$440.00 Million	$5.54 Billion	-1.95pp
2018-12-31	9.90%	$515.00 Million	$5.20 Billion	+5.70pp
2017-12-31	4.20%	$215.00 Million	$5.12 Billion	+2.95pp
2016-12-31	1.25%	$60.00 Million	$4.80 Billion	--
2015-12-31	0.00%	$0.00	$3.36 Billion	--
2014-12-31	0.00%	$0.00	$3.34 Billion	--
2013-12-31	0.00%	$0.00	$2.24 Billion	--
2012-12-31	0.00%	$0.00	$1.97 Billion	--
2011-12-31	29.90%	$75.82 Million	$253.57 Million	+29.61pp
2010-12-31	0.29%	$400.00K	$135.73 Million	-2.49pp
2009-12-31	2.78%	$2.99 Million	$107.40 Million	+1.93pp
2008-12-31	0.85%	$1.00 Million	$117.50 Million	-4.93pp
2007-12-31	5.78%	$12.00 Million	$207.55 Million	+5.65pp
2006-12-31	0.13%	$275.00K	$214.57 Million	-0.05pp
2005-12-31	0.18%	$300.00K	$164.78 Million	--

pp = percentage points

About Jazz Pharmaceuticals PLC

NASDAQ:JAZZ USA Biotechnology

Market Cap

$15.87 Billion

Market Cap Rank

#1694 Global

#644 in USA

Share Price

$252.86

Change (1 day)

-2.14%

52-Week Range

$105.93 - $258.38

All Time High

$258.38